Cytotoxicity evaluation of iron nitride nanoparticles for biomedical applications

Magnetic nanoparticles are widely studied for their use in various therapeutic and diagnostic purposes. As biomaterials, their biocompatibility is as important as their magnetic properties. Iron nitride (FexNy) has excellent magnetic properties, and thus FexNy nanoparticles could be useful as potential biomaterials. However, the biocompatibility of FexNy nanoparticles is yet to be investigated. In this study, we assessed the biocompatibility of FexNy nanoparticles by evaluating their direct-contact cytotoxicity compared with that of magnetite nanoparticles (MNPs). Rat fibroblasts were incubated with the nanoparticle samples dispersed in culture medium at concentrations of 10, 50, and 100 mu g/ml. The DNA concentration measurement, MTT assay, and trypan blue exclusion test were conducted after days 1 and 3 of incubation. After day 1, the cell viability decreased, and cell death increased with increasing sample concentration when compared with the control. However, after day 3, there were no significant differences when compared with the control, irrespective of the sample concentrations. Further, there were no significant differences between the FexNy nanoparticles and MNPs at the same concentrations in all the cytotoxicity evaluation tests. Therefore, it is suggested that FexNy nanoparticles might be as cytocompatible as the conventional MNPs.

Automated summary

The study suggests that FexNy nanoparticles may have comparable cell compatibility to traditional MNPs, showing no significant difference in cell viability decrease at lower concentrations or cell death increase at higher concentrations compared to the control group, indicating potential as biomaterials.